Page last updated: 2024-08-23

metipranolol and Central Serous Chorioretinopathy

metipranolol has been researched along with Central Serous Chorioretinopathy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chrapek, O; Jirkova, B; Kandrnal, V; Rehak, J; Sin, M1

Trials

1 trial(s) available for metipranolol and Central Serous Chorioretinopathy

ArticleYear
Treatment of central serous chorioretinopathy with beta-blocker metipranolol.
    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2015, Volume: 159, Issue:1

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Central Serous Chorioretinopathy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Macula Lutea; Metipranolol; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity

2015